Literature DB >> 26947948

Nonpharmacological Correction of Hypersympatheticotonia in Patients with Chronic Coronary Insufficiency and Severe Left Ventricular Dysfunction.

Sergey A Afanasiev1, Elena N Pavliukova1, Maria A Kuzmichkina1, Tatiana Yu Rebrova1, Yana Anfinogenova2,3, Konstantin S Likhomanov1, Rostislav S Karpov1.   

Abstract

BACKGROUND: Control of sympathetic hyperactivity is pivotal for treatment of heart failure (HF) in patients with coronary artery disease (CAD). Our earlier studies demonstrated that the auricular pulsed electrical stimulation of the vagus nerve (VNS) beneficially affected condition of CAD patients with HF. The aim of our study was to evaluate changes in heart rate (HR) and the levels of heat shock proteins in peripheral blood lymphocytes in patients with CAD in the course of VNS.
METHODS: The study comprised 70 individuals aged 50-68 years with chronic coronary insufficiency, severe left ventricular dysfunction, and NYHA functional class (FC) III-IV HF. Main group included 63 patients who received VNS course (group 1). Control patients (n = 7) received sham therapy (group 2).
RESULTS: According to the results of 6-minute walk test and 24-hour ECG monitoring, administration of VNS improved clinical condition of 58 of 63 patients, decreased HF FC, and attenuated HR. Clinical condition in sham therapy group did not change. Immunoenzyme method demonstrated that hsp70 and hsp60 contents in peripheral blood lymphocyte lysate increased by 58% and 48% (P < 0.05), respectively, in patients who initially had HR < 80 bpm. The hsp70 level significantly increased and hsp60 level remained unchanged in patients with initial HR > 80 bpm.
CONCLUSIONS: Correction of autonomous nervous status by VNS attenuated HR and improved functional state of the heart in CAD patients. Cardiotropic effect of VNS was the most pronounced in patients with preserved endogenous stress-limiting systems associated with hsp60 and/or hsp70.
© 2016 Wiley Periodicals, Inc.

Entities:  

Keywords:  autonomous nervous system; coronary artery disease; heart failure; heart rate, heat shock proteins; vagus nerve stimulation

Mesh:

Substances:

Year:  2016        PMID: 26947948      PMCID: PMC6931422          DOI: 10.1111/anec.12349

Source DB:  PubMed          Journal:  Ann Noninvasive Electrocardiol        ISSN: 1082-720X            Impact factor:   1.468


  43 in total

1.  Chronic vagus nerve stimulation: a new and promising therapeutic approach for chronic heart failure.

Authors:  Gaetano M De Ferrari; Harry J G M Crijns; Martin Borggrefe; Goran Milasinovic; Jan Smid; Markus Zabel; Antonello Gavazzi; Antonio Sanzo; Robert Dennert; Juergen Kuschyk; Srdjan Raspopovic; Helmut Klein; Karl Swedberg; Peter J Schwartz
Journal:  Eur Heart J       Date:  2010-10-28       Impact factor: 29.983

2.  Higher heart rate may predispose to obesity and diabetes mellitus: 20-year prospective study in a general population.

Authors:  Yoshiyuki Shigetoh; Hisashi Adachi; Sho-ichi Yamagishi; Mika Enomoto; Ako Fukami; Maki Otsuka; Shun-ichi Kumagae; Kumiko Furuki; Yasuki Nanjo; Tsutomu Imaizumi
Journal:  Am J Hypertens       Date:  2008-12-11       Impact factor: 2.689

3.  BEAUTIFUL results--the slower, the better?

Authors:  Jan-Christian Reil; Michael Böhm
Journal:  Lancet       Date:  2008-08-29       Impact factor: 79.321

Review 4.  The role of mitochondria in ischemic heart disease.

Authors:  R Ferrari
Journal:  J Cardiovasc Pharmacol       Date:  1996       Impact factor: 3.105

5.  Associations of resting heart rate with concentrations of lipoprotein subfractions in sedentary men.

Authors:  P T Williams; W L Haskell; K M Vranizan; S N Blair; R M Krauss; H R Superko; J J Albers; B Frey-Hewitt; P D Wood
Journal:  Circulation       Date:  1985-03       Impact factor: 29.690

6.  Initiation of stress protein synthesis in the myocardium of coronary patients.

Authors:  S A Afanas'ev; E N Pavlyukova; Sh D Akhmedov; R S Karpov
Journal:  Bull Exp Biol Med       Date:  2004-10       Impact factor: 0.804

Review 7.  Impact of increased heart rate on clinical outcomes in hypertension: implications for antihypertensive drug therapy.

Authors:  Paolo Palatini; Athanase Benetos; Stevo Julius
Journal:  Drugs       Date:  2006       Impact factor: 9.546

8.  Increased cardiac sympathetic nerve activity in heart failure is not due to desensitization of the arterial baroreflex.

Authors:  A M D Watson; S G Hood; R Ramchandra; R M McAllen; C N May
Journal:  Am J Physiol Heart Circ Physiol       Date:  2007-04-13       Impact factor: 4.733

9.  Nonpharmacological Correction of Hypersympatheticotonia in Patients with Chronic Coronary Insufficiency and Severe Left Ventricular Dysfunction.

Authors:  Sergey A Afanasiev; Elena N Pavliukova; Maria A Kuzmichkina; Tatiana Yu Rebrova; Yana Anfinogenova; Konstantin S Likhomanov; Rostislav S Karpov
Journal:  Ann Noninvasive Electrocardiol       Date:  2016-03-07       Impact factor: 1.468

10.  European Guidelines on cardiovascular disease prevention in clinical practice (version 2012). The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts).

Authors:  Joep Perk; Guy De Backer; Helmut Gohlke; Ian Graham; Zeljko Reiner; Monique Verschuren; Christian Albus; Pascale Benlian; Gudrun Boysen; Renata Cifkova; Christi Deaton; Shah Ebrahim; Miles Fisher; Giuseppe Germano; Richard Hobbs; Arno Hoes; Sehnaz Karadeniz; Alessandro Mezzani; Eva Prescott; Lars Ryden; Martin Scherer; Mikko Syvänne; Wilma J M Scholte op Reimer; Christiaan Vrints; David Wood; Jose Luis Zamorano; Faiez Zannad
Journal:  Eur Heart J       Date:  2012-05-03       Impact factor: 29.983

View more
  7 in total

Review 1.  Interdisciplinary approach to compensation of hypoglycemia in diabetic patients with chronic heart failure.

Authors:  Yana Anfinogenova; Elena V Grakova; Maria Shvedova; Kristina V Kopieva; Alexander T Teplyakov; Sergey V Popov
Journal:  Heart Fail Rev       Date:  2018-05       Impact factor: 4.214

2.  Nonpharmacological Correction of Hypersympatheticotonia in Patients with Chronic Coronary Insufficiency and Severe Left Ventricular Dysfunction.

Authors:  Sergey A Afanasiev; Elena N Pavliukova; Maria A Kuzmichkina; Tatiana Yu Rebrova; Yana Anfinogenova; Konstantin S Likhomanov; Rostislav S Karpov
Journal:  Ann Noninvasive Electrocardiol       Date:  2016-03-07       Impact factor: 1.468

3.  Vagus nerve stimulation: Invasive or noninvasive?

Authors:  Yana Anfinogenova
Journal:  Anatol J Cardiol       Date:  2016-10       Impact factor: 1.596

4.  High-Resolution Episcopic Imaging for Visualization of Dermal Arteries and Nerves of the Auricular Cymba Conchae in Humans.

Authors:  Babak Dabiri; Stefan Kampusch; Stefan H Geyer; Van Hoang Le; Wolfgang J Weninger; Jozsef Constantin Széles; Eugenijus Kaniusas
Journal:  Front Neuroanat       Date:  2020-05-12       Impact factor: 3.856

Review 5.  Current Directions in the Auricular Vagus Nerve Stimulation I - A Physiological Perspective.

Authors:  Eugenijus Kaniusas; Stefan Kampusch; Marc Tittgemeyer; Fivos Panetsos; Raquel Fernandez Gines; Michele Papa; Attila Kiss; Bruno Podesser; Antonino Mario Cassara; Emmeric Tanghe; Amine Mohammed Samoudi; Thomas Tarnaud; Wout Joseph; Vaidotas Marozas; Arunas Lukosevicius; Niko Ištuk; Antonio Šarolić; Sarah Lechner; Wlodzimierz Klonowski; Giedrius Varoneckas; Jozsef Constantin Széles
Journal:  Front Neurosci       Date:  2019-08-09       Impact factor: 4.677

Review 6.  International Consensus Based Review and Recommendations for Minimum Reporting Standards in Research on Transcutaneous Vagus Nerve Stimulation (Version 2020).

Authors:  Adam D Farmer; Adam Strzelczyk; Alessandra Finisguerra; Alexander V Gourine; Alireza Gharabaghi; Alkomiet Hasan; Andreas M Burger; Andrés M Jaramillo; Ann Mertens; Arshad Majid; Bart Verkuil; Bashar W Badran; Carlos Ventura-Bort; Charly Gaul; Christian Beste; Christopher M Warren; Daniel S Quintana; Dorothea Hämmerer; Elena Freri; Eleni Frangos; Eleonora Tobaldini; Eugenijus Kaniusas; Felix Rosenow; Fioravante Capone; Fivos Panetsos; Gareth L Ackland; Gaurav Kaithwas; Georgia H O'Leary; Hannah Genheimer; Heidi I L Jacobs; Ilse Van Diest; Jean Schoenen; Jessica Redgrave; Jiliang Fang; Jim Deuchars; Jozsef C Széles; Julian F Thayer; Kaushik More; Kristl Vonck; Laura Steenbergen; Lauro C Vianna; Lisa M McTeague; Mareike Ludwig; Maria G Veldhuizen; Marijke De Couck; Marina Casazza; Marius Keute; Marom Bikson; Marta Andreatta; Martina D'Agostini; Mathias Weymar; Matthew Betts; Matthias Prigge; Michael Kaess; Michael Roden; Michelle Thai; Nathaniel M Schuster; Nicola Montano; Niels Hansen; Nils B Kroemer; Peijing Rong; Rico Fischer; Robert H Howland; Roberta Sclocco; Roberta Sellaro; Ronald G Garcia; Sebastian Bauer; Sofiya Gancheva; Stavros Stavrakis; Stefan Kampusch; Susan A Deuchars; Sven Wehner; Sylvain Laborde; Taras Usichenko; Thomas Polak; Tino Zaehle; Uirassu Borges; Vanessa Teckentrup; Vera K Jandackova; Vitaly Napadow; Julian Koenig
Journal:  Front Hum Neurosci       Date:  2021-03-23       Impact factor: 3.169

Review 7.  Heat shock protein 60 and cardiovascular diseases: An intricate love-hate story.

Authors:  Indumathi Krishnan-Sivadoss; Iván A Mijares-Rojas; Ramiro A Villarreal-Leal; Guillermo Torre-Amione; Anne A Knowlton; C Enrique Guerrero-Beltrán
Journal:  Med Res Rev       Date:  2020-08-17       Impact factor: 12.388

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.